A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
A team of researchers overcomes antibiotic resistance in MRSA by combining antibiotics with irradiation.
Gilbert X. Gonzalez tells how his lab are working on influenza vaccines that can overcome the problems of the seasonal influenza vaccine.
Inactivating viruses from biopharmaceutical source materials can be achieved with detergents. However, the frequently used detergent Triton X-100 is ecotoxic and must be replaced with eco-friendly alternatives.
In 2019, CRISPR gene-editing therapy was used for the first time to treat sickle cell disease.
Pharmacists‐led interventions can significantly reduce medical risk factors, supporting the involvement of pharmacists as healthcare providers in managing patients with hypertension, diabetes and dyslipidaemia.
Unraveling the mystery of viral evolution, scientists discover a similarity between hepatitis A and the Triatoma virus that infects blood-sucking kissing bugs.
A new use for the revolutionary gene-splicing tool. This new “Electrochemical CRISPR” can quickly and accurately identify viral biomarkers for a range of diseases, including HPV and Parvovirus.
The ways astronauts prep for spaceflight could benefit cancer patients, researchers say.
Nanotechnology has emerged as an innovative tool in medicine that could alter the landscape in relation to disease treatment and prevention.
Polymers have been shown to improve the biological capabilities of optical contrast agents to improve diagnosis of diseases such as cancer.
Many nanomaterials can be used to develop inhalable nanomedicines that can be administered with various aerosolization devices.